Avidity Biosciences financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

아트리움 테라퓨틱스NASDAQ:RNA · Nasdaq · Healthcare

$7.84-3.69%

2026-10-02 close

Avidity Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $11M. 2024 operating profit was −$379M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy